Cargando…
Preemptive renal replacement therapy in critically ill patients?
Autores principales: | Meersch, Melanie, Zarbock, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475469/ https://www.ncbi.nlm.nih.gov/pubmed/32953778 http://dx.doi.org/10.21037/atm-2020-110 |
Ejemplares similares
-
Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): study protocol for a randomized controlled trial
por: Zarbock, Alexander, et al.
Publicado: (2016) -
Erratum to: ‘Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury (The ELAIN-Trial): study protocol for a randomized controlled trial’
por: Zarbock, Alexander, et al.
Publicado: (2016) -
Evaluation of Proenkephalin A 119–159 for liberation from renal replacement therapy: an external, multicenter pilot study in critically ill patients with acute kidney injury
por: von Groote, Thilo, et al.
Publicado: (2023) -
Proenkephalin A 119–159 predicts early and successful liberation from renal replacement therapy in critically ill patients with acute kidney injury: a post hoc analysis of the ELAIN trial
por: von Groote, Thilo, et al.
Publicado: (2022) -
Regional citrate versus systemic heparin anticoagulation for continuous renal replacement therapy in critically ill patients with acute kidney injury (RICH) trial: study protocol for a multicentre, randomised controlled trial
por: Meersch, Melanie, et al.
Publicado: (2019)